The orbitofrontal cortex in methamphetamine addiction: Involvement in fear

NeuroReport

Volumn 13, Issue 17, 2002, Pages 2253-2257

  Goldstein, Rita Z ^a   Volkow, Nora D ^a   Chang, Linda ^a   Wang, Gene Jack ^a   Fowler, Joanna S ^a   Depue, Richard A ^b   Gur, Ruben C ^c  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Constraint superfactor; Drug addiction; Fear; Glucose metabolism; Harm avoidance scale; Inhibitory control; Methamphetamine dependence; Normalized relative metabolism; Orbitofrontal cortex; PET FDG; Resting baseline

Indexed keywords

GLUCOSE; METHAMPHETAMINE;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DEPENDENCE; FEAR; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; ORBITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; AGE FACTORS; AMPHETAMINE-RELATED DISORDERS; AVOIDANCE LEARNING; BRAIN MAPPING; ENERGY METABOLISM; EXPLORATORY BEHAVIOR; FEAR; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; SELF-INJURIOUS BEHAVIOR; SEX CHARACTERISTICS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037016166     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200212030-00017     Document Type: Article

References (18)

1. Fischman MW, Schuster CR, Javaid J et al. J Pharmacol Exp Ther 235, 677-682 (1985).
2. Volkow ND, Ding Y-S, Fowler JS et al. J Addict Dis 15, 55-71 (1996).
3. Volkow ND, Fowler JS, Wang G-J et al. Synapse 14, 169-177 (1993).
4. Volkow ND, Fowler JS. Cerebr Cortex 10, 318-325 (2000).
5. Goldstein RZ, Volkow ND, Wang G-J et al. Neuroreport 12, 2595-2599 (2001).
6. Tellegen A and Waller NG. Exploring personality through test construction: Development of the multidimensional personality questionnaire. In: Briggs SR and Cheek JM (eds.), Personality Measures: Development and Evaluation, Vol. 1, Greenwich: JAI Press; 1997.
7. Depue RA and Collins PF. Behav Brain Sci 22, 491-569 (1999).
8. Volkow ND, Chang L, Wang G-J et al. Am J Psychiatry 158, 377-382 (2001).
9. Wang GJ, Volkow ND, Roque CT et al. Radiology 186, 59-65 (1993).
10. Matsui T and Hirano A. An Atlas of the Human Brain for Computerized Tomography. Stuttgart: Gustav Fisher Verlag; 1978.
11. Rolls ET, Hornack J, Wade D and McGrath J. J Neurol Neurosurg Psychiatry 57, 1518-1524 (1994).
12. Saxena S, Brody AL, Schwartz JM and Baxter LR. Br J Psychiatry 35, 26-37 (1998).
13. Chase TN, Geoffrey V, Gillespie M et al. Rev Neurol 142, 851-855 (1986).
14. Veit R, Flor H, Erb M et al. Neurosci Lett 328, 233-236 (2002).
15. Goldstein RZ, Volkow ND. Am J Psychiatry 159, 1642-1652 (2002).
16. Pietrini P, Furey ML, Alexander GE et al. Am J Psychiatry 156, 470-473 (1999).
17. Zald DH, Mattson DL and Pardo JV. Proc Natl Acad Sci 99, 2450-2454 (2002).
18. Volkow ND, Brodie JD, Wolf AP et al. J Cerebr Blood Flow Metab 6, 441-446 (1986).